• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia.介入肾脏病学和血管通路实践:来自南亚和东南亚的观点。
J Vasc Access. 2022 Nov;23(6):849-860. doi: 10.1177/11297298211011375. Epub 2021 May 3.
2
Predialysis nephrology care amongst Palestinian hemodialysis patients and its impact on initial vascular access type.巴勒斯坦血液透析患者的透析前肾脏科护理及其对初始血管通路类型的影响。
Ren Fail. 2020 Nov;42(1):200-206. doi: 10.1080/0886022X.2020.1727512.
3
Practice of dialysis access interventional nephrology procedures in the Asia-Pacific region: Getting lay of the land.亚太地区介入肾脏病学程序中透析通路的实践:了解现状。
Nephrology (Carlton). 2023 Dec;28(12):672-681. doi: 10.1111/nep.14236. Epub 2023 Sep 11.
4
Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas.全球范围内血液透析通路的资金投入和使用情况的差异:基于 ISN 全球肾脏健康地图的国际报告。
BMC Nephrol. 2024 May 8;25(1):159. doi: 10.1186/s12882-024-03593-z.
5
Vascular access types in patients starting hemodialysis after failed kidney transplant: does close nephrology follow-up matter?肾移植失败后开始血液透析的患者的血管通路类型:肾脏病密切随访重要吗?
J Vasc Access. 2017 Jan 18;18(1):22-25. doi: 10.5301/jva.5000631. Epub 2016 Nov 28.
6
Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study.与腹膜透析相比,使用动静脉瘘或中心静脉导管开始血液透析的效果:一项回顾性队列研究。
BMC Nephrol. 2012 Aug 23;13:88. doi: 10.1186/1471-2369-13-88.
7
Predialysis nephrology care and its impact on initial vascular access type in hemodialysis patients in Jordan.透析前肾脏病护理及其对约旦血液透析患者初始血管通路类型的影响。
Saudi J Kidney Dis Transpl. 2019 Sep-Oct;30(5):1103-1110. doi: 10.4103/1319-2442.270266.
8
Interventional nephrology in Brazil: current and future status.巴西的介入肾脏病学:现状与未来发展
Semin Dial. 2006 Mar-Apr;19(2):172-5. doi: 10.1111/j.1525-139X.2006.00146.x.
9
Impact of training in interventional nephrology on hemodialysis vascular access types.介入肾脏病学培训对血液透析血管通路类型的影响。
Semin Dial. 2009 Jan-Feb;22(1):90-2. doi: 10.1111/j.1525-139X.2008.00508.x. Epub 2008 Oct 16.
10
Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.在内城肾病诊所就诊的慢性肾脏病4期和5期患者的血管通路置入:一项队列研究及对医疗服务提供者的调查
BMC Nephrol. 2017 Jan 17;18(1):28. doi: 10.1186/s12882-016-0431-3.

引用本文的文献

1
Building Interventional Nephrology Skills in India: A Decade-Long Journey by the AVATAR Foundation.印度介入肾脏病学技能的培养:阿凡达基金会的十年历程
Kidney Int Rep. 2025 Feb 28;10(4):983-987. doi: 10.1016/j.ekir.2025.02.020. eCollection 2025 Apr.
2
Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas.全球范围内血液透析通路的资金投入和使用情况的差异:基于 ISN 全球肾脏健康地图的国际报告。
BMC Nephrol. 2024 May 8;25(1):159. doi: 10.1186/s12882-024-03593-z.
3
Capacity for the management of kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).国际肾脏病学会南亚地区肾衰竭管理能力:来自2023年国际肾脏病学会全球肾脏健康地图(ISN-GKHA)的报告
Kidney Int Suppl (2011). 2024 Apr;13(1):123-135. doi: 10.1016/j.kisu.2024.01.007. Epub 2024 Apr 8.
4
Practice of dialysis access interventional nephrology procedures in the Asia-Pacific region: Getting lay of the land.亚太地区介入肾脏病学程序中透析通路的实践:了解现状。
Nephrology (Carlton). 2023 Dec;28(12):672-681. doi: 10.1111/nep.14236. Epub 2023 Sep 11.
5
Arteriovenous fistula creation by nephrologist and its outcomes: a prospective cohort study from Vietnam.肾脏病学家创建动静脉瘘及其结果:来自越南的前瞻性队列研究。
BMC Nephrol. 2023 Apr 4;24(1):88. doi: 10.1186/s12882-023-03123-3.

本文引用的文献

1
The state of nephrology in South Asia.南亚的肾脏病学状况。
Kidney Int. 2019 Jan;95(1):31-37. doi: 10.1016/j.kint.2018.09.001. Epub 2018 Oct 26.
2
Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India.印度接受公共资金资助血液透析患者的使用情况、费用及治疗结果。
Kidney Int. 2018 Sep;94(3):440-445. doi: 10.1016/j.kint.2018.03.028.
3
Nephrology in the Oceania-South East Asia region: perspectives and challenges.大洋洲-东南亚地区的肾脏病学:现状与挑战
Kidney Int. 2018 Sep;94(3):465-470. doi: 10.1016/j.kint.2018.05.014. Epub 2018 Jul 23.
4
Survey of Kidney Biopsy Clinical Practice and Training in the United States.美国肾脏活检临床实践与培训调查。
Clin J Am Soc Nephrol. 2018 May 7;13(5):718-725. doi: 10.2215/CJN.13471217. Epub 2018 Apr 18.
5
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际间血液透析用动静脉通路位置与使用的差异:来自透析结局和实践模式研究(DOPPS)的结果。
Am J Kidney Dis. 2018 Apr;71(4):469-478. doi: 10.1053/j.ajkd.2017.09.012. Epub 2017 Dec 1.
6
Problems Associated With Access to Renal Replacement Therapy: Experience of the Sindh Institute of Urology and Transplantation.获得肾脏替代治疗相关问题:信德省泌尿外科与移植研究所的经验
Exp Clin Transplant. 2017 Feb;15(Suppl 1):46-49. doi: 10.6002/ect.mesot2016.O27.
7
Sustainability of the Peritoneal Dialysis-First Policy in Hong Kong.香港腹膜透析优先政策的可持续性。
Blood Purif. 2015;40(4):320-5. doi: 10.1159/000441580. Epub 2015 Nov 17.
8
Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons.美国血管通路使用、患者偏好和相关实践的趋势:来自美国 DOPPS 实践监测的最新信息以及国际比较。
Am J Kidney Dis. 2015 Jun;65(6):905-15. doi: 10.1053/j.ajkd.2014.12.014. Epub 2015 Feb 7.
9
A Global Overview of the Impact of Peritoneal Dialysis First or Favored Policies: An Opinion.腹膜透析优先或优惠政策影响的全球概述:一种观点。
Perit Dial Int. 2015 Jul-Aug;35(4):406-20. doi: 10.3747/pdi.2013.00204. Epub 2014 Jul 31.
10
Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study.巴基斯坦卡拉奇市慢性肾脏病的流行情况、决定因素和管理:一项基于社区的横断面研究。
BMC Nephrol. 2014 Jun 13;15:90. doi: 10.1186/1471-2369-15-90.

介入肾脏病学和血管通路实践:来自南亚和东南亚的观点。

Interventional nephrology and vascular access practice: A perspective from South and Southeast Asia.

机构信息

PGIMER, Chandigarh, India.

Sir Ganga Ram Hospital, India.

出版信息

J Vasc Access. 2022 Nov;23(6):849-860. doi: 10.1177/11297298211011375. Epub 2021 May 3.

DOI:10.1177/11297298211011375
PMID:33934667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7615897/
Abstract

South and Southeast Asia is the most populated, heterogeneous part of the world. The Association of Vascular Access and InTerventionAl Renal physicians (AVATAR Foundation), India, gathered trends on epidemiology and Interventional Nephrology (IN) for this region. The countries were divided as upper-middle- and higher-income countries as Group-1 and lower and lower-middle-income countries as Group-2. Forty-three percent and 70% patients in the Group 1 and 2 countries had unplanned hemodialysis (HD) initiation. Among the incident HD patients, the dominant Vascular Access (VA) was non-tunneled central catheter (non-TCC) in 70% of Group 2 and tunneled central catheter (TCC) in 32.5% in Group 1 countries. Arterio-Venous Fistula (AVF) in the incident HD patients was observed in 24.5% and 35% of patients in Group-2 and Group-1, respectively. Eight percent and 68.7% of the prevalent HD patients in Group-2 and Group-1 received HD through an AVF respectively. Nephrologists performing any IN procedure were 90% and 60% in Group-2 and Group 1, respectively. The common procedures performed by nephrologists include renal biopsy (93.3%), peritoneal dialysis (PD) catheter insertion (80%), TCC (66.7%) and non-TCC (100%). Constraints for IN include lack of time (73.3%), lack of back-up (40%), lack of training (73.3%), economic issues (33.3%), medico-legal problems (46.6%), no incentive (20%), other interests (46.6%) and institution not supportive (26%). Routine VA surveillance is performed in 12.5% and 83.3% of Group-2 and Group-1, respectively. To conclude, non-TCC and TCC are the most common vascular access in incident HD patients in Group-2 and Group-1, respectively. Lack of training, back-up support and economic constraints were main constraints for IN growth in Group-2 countries.

摘要

南亚和东南亚是世界上人口最多、最多样化的地区。印度的血管通路和介入肾脏病协会(AVATAR 基金会)收集了该地区的流行病学和介入肾脏病学趋势。这些国家被分为中上收入和高收入国家(第 1 组)和低收入和中下收入国家(第 2 组)。第 1 组和第 2 组国家中,43%和 70%的血液透析(HD)患者为非计划性开始 HD。在新发生的 HD 患者中,第 2 组国家 70%的主要血管通路(VA)为非隧道中央导管(非 TCC),第 1 组国家 32.5%为隧道中央导管(TCC)。新发生的 HD 患者中,动静脉瘘(AVF)分别占第 2 组和第 1 组患者的 24.5%和 35%。第 2 组和第 1 组中分别有 8%和 68.7%的现患 HD 患者通过 AVF 接受 HD。在第 2 组和第 1 组中,分别有 90%和 60%的肾脏病学家进行任何介入治疗。肾脏病学家进行的常见操作包括肾活检(93.3%)、腹膜透析(PD)导管插入术(80%)、TCC(66.7%)和非 TCC(100%)。介入治疗的限制因素包括缺乏时间(73.3%)、缺乏后备支持(40%)、缺乏培训(73.3%)、经济问题(33.3%)、医学法律问题(46.6%)、无激励措施(20%)、其他利益(46.6%)和机构不支持(26%)。第 2 组和第 1 组分别有 12.5%和 83.3%的患者常规进行 VA 监测。结论:在第 2 组和第 1 组的新发生 HD 患者中,非 TCC 和 TCC 是最常见的血管通路。缺乏培训、后备支持和经济限制是第 2 组国家介入治疗发展的主要限制因素。